Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Rein Therapeutics (RNTX) Debt to Equity (2018 - 2021)

Rein Therapeutics filings provide 3 years of Debt to Equity readings, the most recent being $0.01 for Q1 2021.

  • For the quarter ending Q1 2021, Debt to Equity changed N/A year-over-year to $0.01, compared with a TTM value of $0.01 through Mar 2021, changed N/A, and an annual FY2020 reading of $0.03, changed N/A over the prior year.
  • Debt to Equity hit $0.01 in Q1 2021 for Rein Therapeutics, down from $0.03 in the prior quarter.
  • The five-year high for Debt to Equity was $0.27 in Q4 2018, with the low at $0.01 in Q1 2021.
  • Median Debt to Equity over the past 3 years was $0.03 (2020), compared with a mean of $0.09.